← All indications
Mucocutaneous Lymph Node Syndrome
An acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, and edema or erythema of the extremities.
Drugs by status
Phase 4 trials (4)
Phase 2 trials (6)
Phase 1 trials (1)
Organizations
Organization Involved with Phase 4 Indications (3)
Organization Involved with Phase 3 Indications (25)
- Swedish Orphan Biovitrum
- Baxalta
- Lantheus Medical Imaging
- National Heart, Lung, and Blood Institute (NHLBI)
- Huazhong University of Science and Technology
- Cancer Research Network
- New England Research Institutes
- Ohio State University
- Stanford University
- University of South Florida
- Yokohama City University
- Fudan University
- University of California, San Diego
- Jiao Tong University
- National Taiwan University
- Rush University
- Mitsubishi Tanabe
- Allergy Associates of the Palm Beaches, North Palm Beach, FL
- Allergy, Asthma & Immunology Assoc., Omaha, NE
- First Allergy and Clinical Research Center, Engelwood, CO
- Asthma and Allergy Center, Papillion, NE
- Pediatric Allergy/Immunology Associates, Dallas, TX
- Yeshiva University
- Assistance Publique - Hôpitaux de Paris
- The University of Texas, Dallas
Organization Involved with Phase 2 Indications (13)
Organization Involved with Phase 1 Indications (2)